• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  Centruroides immune F(ab)2
Trade Name:  Anascorp
Date Designated:  06/12/2000
Orphan Designation:  Treatment of scorpion envenomations requiring medical attention.
Orphan Designation Status:  Designated/Approved
Marketing Approval Date:  08/04/2011 
Approved Labeled Indication:  Treatment of clinical signs of scorpion envenomation
Exclusivity End Date:    08/04/2018 
Exclusivity Protected Indication* :  
Rare Disease Therapeutics, Inc.
12975 Brookprinter Drive
Suite 170
Poway, California 92064
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.